ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arkansas » Neurology

Top Neurology Prescribers in Arkansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID OBERLANDER M.D.

Neurology

8,207

$636K

548
184 are 65+

26%
patients receiving schedule two controlled substances

Avg: 2%

44%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

11%
prescriptions for brand name drugs

Avg: 22%

$78
Average prescription price

Avg: $224

KENNETH CHAN D.O.

Neurology

5,358

$1.01M

468
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 22%

$189
Average prescription price

Avg: $224

MARGARET TREMWEL MD

Neurology

5,232

$714K

425
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 22%

$136
Average prescription price

Avg: $224

JANICE KEATING MD

Neurology

5,008

$849K

473
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 22%

$170
Average prescription price

Avg: $224

KEITH SCHLUTERMAN M.D.

Neurology

4,680

$788K

401
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 22%

$168
Average prescription price

Avg: $224

TONYA PHILLIPS MD

Neurology

4,593

$1.86M

419
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

41%
prescriptions for brand name drugs

Avg: 22%

$406
Average prescription price

Avg: $224

JOHN KAREUS DO

Neurology

4,548

$1.76M

441
288 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 22%

$388
Average prescription price

Avg: $224

ROBERT ARCHER MD

Neurology

4,341

$4.03M

275
87 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

37%
prescriptions for brand name drugs

Avg: 22%

$929
Average prescription price

Avg: $224

BING BEHRENS MD

Neurology

4,292

$787K

392
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 22%

$183
Average prescription price

Avg: $224

WILLIAM KNUBLEY MD

Neurology

4,133

$1.34M

345
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 22%

$325
Average prescription price

Avg: $224

KATHRYN CHENAULT MD

Neurology

3,882

$1.25M

403
236 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$321
Average prescription price

Avg: $224

IKRAM KHAN MD

Neurology

3,874

$1.06M

397
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 22%

$274
Average prescription price

Avg: $224

MARK PIPPENGER M.D.

Neurology

3,561

$335K

449
362 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 22%

$94
Average prescription price

Avg: $224

JOHN TOWBIN M.D.

Neurology

3,466

$986K

177
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

52%
prescriptions for brand name drugs

Avg: 22%

$285
Average prescription price

Avg: $224

TIMOTHY FREYALDENHOVEN MD

Neurology

3,435

$466K

336
205 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$136
Average prescription price

Avg: $224

JAMES THOMAS M.D.

Neurology

3,255

$657K

428
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 22%

$202
Average prescription price

Avg: $224

RONALD SOUTH M.D.

Neurology

3,195

$546K

349
226 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

38%
prescriptions for brand name drugs

Avg: 22%

$171
Average prescription price

Avg: $224

ALAN DIAMOND DO

Neurology

3,021

$476K

359
304 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 22%

$157
Average prescription price

Avg: $224

WILLIS COURTNEY MD

Neurology

2,703

$639K

293
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$237
Average prescription price

Avg: $224

WANDAL MONEY MD

Neurology

2,673

$150K

185
56 are 65+

22%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 4%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $224

VLADIMIR KARPITSKIY MD

Neurology

2,640

$248K

341
234 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

10%
prescriptions for brand name drugs

Avg: 22%

$94
Average prescription price

Avg: $224

CHRISTOPHER WRIGHT M.D.

Neurology

2,632

$250K

331
203 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$95
Average prescription price

Avg: $224

DUANE BIRKY MD

Neurology

2,572

$744K

245
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 22%

$289
Average prescription price

Avg: $224

MARIO CAULI M.D.

Neurology

2,537

$466K

324
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 22%

$184
Average prescription price

Avg: $224

BRADLEY BOOP M.D.

Neurology

2,522

$319K

249
172 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$126
Average prescription price

Avg: $224

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank